Frank P. Luyten
Directeur/Bestuurslid bij PharmaCell BV
Profiel
Frank P.
Luyten is the founder of TiGenix NV, which was founded in 2000.
He held the position of Non-Executive Director from 2010 to 2011.
Currently, he is the Chairman of the Muscoskeletal Sciences Department at Université Catholique de Louvain, Director at Prometheus, Director at Laboratory for Skeletal Development & Joint Disorders, and Member of the Supervisory Board at PharmaCell BV and Neuroplast BV.
He previously worked as a Principal at the National Institutes of Health and as a Professor & Head of the Rheumatology Division at Universitaire Ziekenhuizen Leuven.
He received his doctorate degree from Ghent University.
Actieve functies van Frank P. Luyten
Bedrijven | Functie | Begin |
---|---|---|
PharmaCell BV
PharmaCell BV BiotechnologyHealth Technology PharmaCell BV manufactures cell therapy and regenerative medicine. The firm engages in human cell line development and manufacturing of bio pharmaceuticals. Its services include process research and development, project management, incoming logistics, incoming goods, manufacturing auto logous and allogeneic products, quality control, final formulation, release and outgoing logistics. The company was founded by René Lardenoije and Jan Thio in 2005 and is headquartered in Maastricht, the Netherlands. | Directeur/Bestuurslid | 15-04-2010 |
Laboratory for Skeletal Development & Joint Disorders | Directeur/Bestuurslid | 14-10-2010 |
Prometheus
Prometheus Packaged SoftwareTechnology Services Prometheus is an independent network of four southern-European think tanks that specialize in economic, business, and geopolitical research. The private company is based in Antwerp, Belgium, and have subsidiaries in Belgium. Prometheus recently published a report on the music production and reproduction ecosystem. The Belgian company was founded in 2006 by Clyde Davis. | Directeur/Bestuurslid | 14-10-2010 |
Université Catholique de Louvain | Corporate Officer/Principal | 24-10-2011 |
Neuroplast BV
Neuroplast BV BiotechnologyHealth Technology Neuroplast BV is a Dutch stem cell technology company that focuses on developing autologous cell products for the treatment of primarily inflammation-driven neurological disorders. Neuroplast is located in Brightlands Chemelot Campus in the Netherlands. The company's transformative treatment, Neuro-cellsò, is currently being tested for traumatic spinal cord injury (TSCI) and aims to reduce the irreversible impact of TSCI during the crucial first phase. The company was founded in August 2014 by physician De Munter and neurologist Erik Wolters, and current investors include Invest, Brightlands Venture Partners, and Liof NV. Johannes de Munter has been the CEO of the company since 2016. | Directeur/Bestuurslid | 21-10-2021 |
Eerdere bekende functies van Frank P. Luyten
Bedrijven | Functie | Einde |
---|---|---|
TIGENIX NV | Oprichter | 03-05-2011 |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
Universitaire Ziekenhuizen Leuven
Universitaire Ziekenhuizen Leuven Hospital/Nursing ManagementHealth Services Universitaire Ziekenhuizen Leuven provides medical services. It offers abdominal surgery, abdominal transplant surgery and coordination, breast centre, cardiac surgery, dentistry, emergency medicine, endocrinology and haematology. The company was founded in 1080 and is headquartered in Leuven, Belgium. | Corporate Officer/Principal | - |
Opleiding van Frank P. Luyten
Ghent University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 7 |
---|---|
TiGenix NV
TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium. | Health Technology |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
PharmaCell BV
PharmaCell BV BiotechnologyHealth Technology PharmaCell BV manufactures cell therapy and regenerative medicine. The firm engages in human cell line development and manufacturing of bio pharmaceuticals. Its services include process research and development, project management, incoming logistics, incoming goods, manufacturing auto logous and allogeneic products, quality control, final formulation, release and outgoing logistics. The company was founded by René Lardenoije and Jan Thio in 2005 and is headquartered in Maastricht, the Netherlands. | Health Technology |
Prometheus
Prometheus Packaged SoftwareTechnology Services Prometheus is an independent network of four southern-European think tanks that specialize in economic, business, and geopolitical research. The private company is based in Antwerp, Belgium, and have subsidiaries in Belgium. Prometheus recently published a report on the music production and reproduction ecosystem. The Belgian company was founded in 2006 by Clyde Davis. | Technology Services |
Universitaire Ziekenhuizen Leuven
Universitaire Ziekenhuizen Leuven Hospital/Nursing ManagementHealth Services Universitaire Ziekenhuizen Leuven provides medical services. It offers abdominal surgery, abdominal transplant surgery and coordination, breast centre, cardiac surgery, dentistry, emergency medicine, endocrinology and haematology. The company was founded in 1080 and is headquartered in Leuven, Belgium. | Health Services |
Laboratory for Skeletal Development & Joint Disorders | |
Neuroplast BV
Neuroplast BV BiotechnologyHealth Technology Neuroplast BV is a Dutch stem cell technology company that focuses on developing autologous cell products for the treatment of primarily inflammation-driven neurological disorders. Neuroplast is located in Brightlands Chemelot Campus in the Netherlands. The company's transformative treatment, Neuro-cellsò, is currently being tested for traumatic spinal cord injury (TSCI) and aims to reduce the irreversible impact of TSCI during the crucial first phase. The company was founded in August 2014 by physician De Munter and neurologist Erik Wolters, and current investors include Invest, Brightlands Venture Partners, and Liof NV. Johannes de Munter has been the CEO of the company since 2016. | Health Technology |